Migraine is a neurological disorder that causes severe pain in head and results in nausea, vomiting, and extreme sensitivity to light and sound. The common types of migraine are with aura and without aura that means classical migraines and common migraines.

According to migraine trust website, in 2016, migraine headaches affected about 12.0% to 14.7% of population across the globe. Migraine has been categorized by frequency and nature of attack into episodic migraine and chronic migraine as per international as well regional guidelines. Migraine is an extraordinarily prevalent neurological disease, affecting 39 million men, women and children in the US and 1 billion worldwide. As per World Health Organization (WHO) in 2016, about 50% of migraine disorders were reported, out of which, women patients were more.

Request for Sample Report – https://www.gmiresearch.com/report/global-migraine-drugs-market/sample-request

Rise in prevalence of migraine in the age group of 30 to 40 drives the migraine drugs market. Moreover, increase in female population and surge in awareness among patients related to prevention and treatment of migraine are the key factors that augment the growth of the market. However, side effects like fatigue, nausea, lowering of blood pressure, etc., associated with migraine drugs is a factor that hinders the market growth. Migraine disorders are among the most common disorders of the nervous system, mostly observed in adult population. Furthermore, North America holds the largest share in the migraine drugs market as it has large number of ageing population.

Various notable players operating in the global migraine drugs market include Abbott Laboratories, Aegis Therapeutics, LLC, Aerial Biopharma LLC, Alder Biopharmaceuticals Inc., Amgen Inc, Astellas Pharma, AstraZeneca, Johnsons and Johnsons, Eisai Co Ltd, Eli Lily & Co and others.

The global migraine drugs market has been segmented on the basis of drug type, route of administration, end user and key geographies. Based on the drug type, the market comprises of abortive drugs and preventive drugs. Based on route of administration, the market is classified into Oral, Injectables and Others. Based on end user market is segmented into Hospital pharmacies, retail pharmacies and others.

This research report “global migraine drugs market” provides in-depth analysis of the migraine drugs market across the globe based on drug type, route of administration, end user and major geographies for the forecast period from 2018 to 2025. The report highlights the major market drivers propelling the growth as well as challenges faced by market participants. The research report provides market size and forecast for migraine drugs market. The report also analyses the competitive landscape, major players and their strategies in 2018. The competitive landscape section of the report captures and highlights the recent developments in the market.

Request for Customization – https://www.gmiresearch.com/report/global-migraine-drugs-market/request-for-customization

Key questions answered in this research report:
1. At what pace is migraine drugs market growing worldwide? What will be growth trend in future?
2. What are the key drivers and restraints in the current market? What will be the impact of drivers and restraints in the future?
3. What are the regional revenue and forecast breakdowns? Which are the major regional revenue pockets for growth in the migraine drugs market?
4. What are the various application areas and how they are poised to grow?

The global migraine drugs market has been segmented based on drug type, route of administration, end user and geography:

Global Migraine Drugs Market, by Drug Type
• Abortive Drugs
• Preventive Drugs

Global Migraine Drugs Market, by Route of Administration
• Oral
• Injectables
• Others (Nasal Spray, Transdermal Path, etc.)

Global Migraine Drugs Market, by End User
• Hospitals Pharmacies
• Retail Pharmacies
• Others

Global Migraine Drugs Market, by Geography
• North America
As a part of customization
o By Drug Type
o By Route of Administration
o By End User
o United States
o Canada
o Mexico

• Europe
As a part of customization
o By Drug Type
o By Route of Administration
o By End User
o United Kingdom
o Germany
o Spain
o Rest of Europe

• Asia-Pacific
As a part of customization
o By Drug Type
o By Route of Administration
o By End User
o China
o Japan
o India
o Rest of Asia-Pacific

• Rest of the World
As a part of customization
o By Drug Type
o By Route of Administration
o By End User
o Brazil
o GCC countries
o South Africa
o Rest of ROW

Global Migraine Drugs Market Competitive Landscape

• Major Players and their Key Strategies
• New Drug Launches
• Mergers and Acquisitions
• Collaborations, Partnerships, Agreements and Joint Ventures

Leading Market Players
• Abbott Laboratories
• Aegis Therapeutics, LLC
• Aerial Biopharma LLC
• Alder Biopharmaceuticals Inc.,
• Amgen Inc Lucibel SA
• Astellas Pharma.
• AstraZeneca Velmenni OÜ
• Johnsons and Johnsons
• Eisai Co Ltd
• Eli Lily & Co

Other prominent players in the market which can be profiled as a part of customization:
• Teva Pharmaceutical Industries Ltd.
• GlaxoSmithKline plc
• Novartis AG
• Merck & Co., Inc.,

For more details, browse the Table of Contents: https://www.gmiresearch.com/report/global-migraine-drugs-market/

About GMI Research

GMI Research is a market research and consulting firm which provides research-based solutions to business executives and investment professionals so that they can make right business & investment decisions faster based on real facts. We help business leaders through independent fact-based insight, ensuring their business achieve success by beating the competition.

GMI Research leverages its industry expertise and experience to identify the industry trends, big opportunities and potential growth areas across industries. Our Syndicated reports provide actionable insights and covers industry trends, market drivers & restraints, macroeconomics factors, market estimates & forecasts, competitive landscape etc. which helps our clients to strengthen its market position by deploying specific strategies and actions that will lead to higher growth.

Media Contact
Company Name: GMI RESEARCH
Contact Person: Media Relations
Email: Send Email
Phone: +353 1 442 8820
Address:Level 1, The Chase Carmanhall Road, Sandyford Industrial Estate
City: Dublin
State: Dublin
Country: Ireland
Website: www.gmiresearch.com